Sezer ED, Sozmen EY, Nart D, Onat T (2011)
Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation
Vasc Health Risk Manag 7: 333

Kayikcioglu M, Saygi S, Azarsiz E, Can LH, Kultursay H, Sozmen EY (2007)
Serum paraoxonase 1 activity and oxidative markers of LDL in patients with cardiac syndrome X
Acta Cardiol 62: 245

Sozmen B, Peker S, Kaya U, Erkan M, Sozmen EY (2007)
Markers of long-term exposure to organophosphorus pesticides in farmers who work in viniculture and tobacco production in Turkey
Toxicol Mech Methods 17: 379

Akcay YD, Sagin FG, Sendag F, Oztekin K, Sozmen EY (2006)
Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role?
Maturitas 53: 325

Ak G, Ozgonul M, Sozmen EY, Aslan SL, Sozmen B (2002)
Renal cortical thickness and PON1 activity both decrease in chronic renal failure
J Nephrol 15: 144

Sozmen EY, Mackness B, Sozmen B, Durrington P, Girgin FK, Aslan L, Mackness MI (2002)
Effect of organophosphate intoxication on human serum paraoxonase
Hum Exp Toxicol 21: 247

Sozmen EY, Sozmen B, Delen Y, Onat T (2001)
Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control
Arch Med Res 32: 283

Sozmen EY, Sozmen B, Girgin FK, Delen Y, Azarsiz E, Erdener D, Ersoz B (2001)
Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation
Clin Exp Med 1: 195

Akgur SA, Ozturk P, Sozmen EY, Delen Y, Tanyalcin T, Ege B (1999)
Paraoxonase and acetylcholinesterase activities in humans exposed to organophosphorous compounds
J Toxicol Environ Health 58: 469

Sozmen B, Delen Y, Girgin FK, Sozmen EY (1999)
Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control
Clinical Biochemistry 32: 423